Pediatric patients with angiosarcoma were found to have a higher survival rate than their adult counterparts and may benefit from more aggressive treatments.

A pooled analysis of individual data from 5 COG studies demonstrated that race/ethnicity has no significant effect on survival for children and AYAs with cancer receiving treatment on clinical trial.

Results of a randomized, placebo-controlled study demonstrated avatrombopag achieved the primary endpoint of platelet response in heavily pretreated pediatric patients with persistent or chronic ITP.

Overall survival after HCT for high-risk features in patients with SDS was superior to OS for HCT for MDS/AML, particularly ...

The risk of mortality for patients with colon cancer is significantly higher for those with cannabis-use disorder, compared with use disorders of other substances.

Recent novel treatments for chronic lymphocytic leukemia (CLL), such as second-generation covalent Bruton tyrosine kinase inhibitors (cBTKis) and venetoclax-obinutuzumab (VenO), may offer better ...

Researchers examined patient-reported outcomes for quality of life following Mohs micrographic surgery for facial skin cancer.

Relative survival increased from 64% to 66%, overall survival from 54% to 55%, and lymphoma-specific survival from 64% to 66%.

Using data from the Global Burden of Disease 2021 database, researchers identified specific etiologies and other factors contributing to the burden of primary liver cancer in patients across the ...

Researchers found a significant tradeoff between harms and benefits for patients who received an ICI plus chemotherapy in the first-line setting.

Combination treatment with a PARP inhibitor and an anti-angiogenic agent did not improve PFS when compared to chemotherapy or ...

A literature review explored the omics-based approach to symptom biomarker identification to determine how these biomarkers affect symptom management strategies.